Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 2
1966 5
1968 3
1971 5
1972 1
1973 1
1974 2
1975 1
1976 2
1977 4
1999 1
2006 3
2007 2
2009 3
2010 6
2011 8
2012 5
2013 6
2014 3
2015 5
2016 2
2017 5
2019 2
2020 7
2021 3
2022 7
2023 5
2024 5
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

94 results

Results by year

Filters applied: . Clear all
Page 1
Empagliflozin in Patients with Chronic Kidney Disease.
The EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, Judge P, Mayne KJ, Ng SYA, Sammons E, Zhu D, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu W, Kadowaki T, Nangaku M, Levin A, Cherney D, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Petrini M, Massey D, Eilbracht J, Brueckmann M, Landray MJ, Baigent C, Haynes R. The EMPA-KIDNEY Collaborative Group, et al. N Engl J Med. 2023 Jan 12;388(2):117-127. doi: 10.1056/NEJMoa2204233. Epub 2022 Nov 4. N Engl J Med. 2023. PMID: 36331190 Free PMC article. Clinical Trial.
Frailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.
Mayne KJ, Sardell RJ, Staplin N, Judge PK, Zhu D, Sammons E, Cherney DZI, Cheung AK, Maggioni AP, Nangaku M, Rossello X, Tuttle KR, Ihara K, Iwata T, Wanner C, Emberson J, Preiss D, Landray MJ, Baigent C, Haynes R, Herrington WG; EMPA-KIDNEY Collaborative Group. Mayne KJ, et al. Clin J Am Soc Nephrol. 2024 Sep 1;19(9):1119-1129. doi: 10.2215/CJN.0000000000000498. Epub 2024 Jun 27. Clin J Am Soc Nephrol. 2024. PMID: 40179340 Free PMC article. Clinical Trial.
Growth Abnormalities of Fetuses and Infants.
Cosmi E, Grisan E, Fanos V, Rizzo G, Sivanandam S, Visentin S. Cosmi E, et al. Among authors: sivanandam s. Biomed Res Int. 2017;2017:3191308. doi: 10.1155/2017/3191308. Epub 2017 Nov 22. Biomed Res Int. 2017. PMID: 29359148 Free PMC article. No abstract available.
Field's stain--a rapid staining method for Acanthamoeba spp.
Pirehma M, Suresh K, Sivanandam S, Anuar AK, Ramakrishnan K, Kumar GS. Pirehma M, et al. Among authors: sivanandam s. Parasitol Res. 1999 Oct;85(10):791-3. doi: 10.1007/s004360050634. Parasitol Res. 1999. PMID: 10494803
Dot in Circle Sign.
Indiran V, Sivanandam SP. Indiran V, et al. Among authors: sivanandam sp. Oman Med J. 2020 Jul 30;35(4):e156. doi: 10.5001/omj.2020.77. eCollection 2020 Jul. Oman Med J. 2020. PMID: 32802415 Free PMC article. No abstract available.
Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial.
Zhou J, Williams C, Staplin N, Judge PK, Mayne KJ, Agrawal N, Arimoto R, Green JB, Cherney DZI, Tuttle KR, Leal J, Clarke P, Emberson JR, Preiss D, Wanner C, Landray MJ, Baigent C, Haynes R, Herrington WG, Mihaylova B; EMPA-KIDNEY Collaborative Group. Zhou J, et al. EClinicalMedicine. 2025 Jul 8;85:103338. doi: 10.1016/j.eclinm.2025.103338. eCollection 2025 Jul. EClinicalMedicine. 2025. PMID: 40686671 Free PMC article.
"Vanishing" pulmonary valve stenosis.
Arain NI, Moller JH, Pyles LA, Sivanandam S. Arain NI, et al. Among authors: sivanandam s. Ann Pediatr Cardiol. 2012 Jan;5(1):47-50. doi: 10.4103/0974-2069.93711. Ann Pediatr Cardiol. 2012. PMID: 22529602 Free PMC article.
94 results